Cahill Financial Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$261K Sell
1,370
-58
-4% -$9.97K 0.03% 267
2026
Q1
$241K Sell
1,428
-69
-5% -$11.8K 0.03% 265
2025
Q4
$253K Sell
1,497
-104
-6% -$16.9K 0.03% 260
2025
Q3
$231K Buy
1,601
+1
+0.1% +$136 0.03% 269
2025
Q2
$202K Hold
1,600
0.03% 269
2025
Q1
$205K Buy
1,600
+1
+0.1% +$136 0.03% 260
2024
Q4
$211K Sell
1,599
-21
-1% -$2.95K 0.03% 250
2024
Q3
$236K Sell
1,620
-229
-12% -$33.1K 0.03% 232
2024
Q2
$254K Hold
1,849
0.03% 237
2024
Q1
$254K Sell
1,849
-991
-35% -$135K 0.03% 234
2023
Q4
$386K Sell
2,840
-610
-18% -$74.4K 0.06% 181
2023
Q3
$422K Buy
3,450
+8
+0.2% +$1.02K 0.07% 169
2023
Q2
$437K Buy
3,442
+759
+28% +$98.6K 0.07% 173
2023
Q1
$346K Sell
2,683
-1,267
-32% -$166K 0.06% 178
2022
Q4
$519K Buy
3,950
+1,322
+50% +$171K 0.1% 147
2022
Q3
$307K Buy
+2,628
New +$326K 0.06% 180
2018
Q4
Sell
-2,926
Closed -$357K 149
2018
Q3
$357K Buy
2,926
+1,000
+52% +$118K 0.16% 123
2018
Q2
$212K Buy
+1,926
New +$206K 0.1% 147
2017
Q4
Sell
-2,148
Closed -$239K 141
2017
Q3
$239K Buy
+2,148
New +$230K 0.13% 123

Other funds holding IBB

Cahill Financial Advisors's IBB Position: Q2 2026 in Review

Cahill Financial Advisors reduced its iShares Biotechnology ETF (IBB) stake by 4.1% in Q2 2026, selling an estimated $9.97K and leaving 1,370 shares worth $261K. The position accounts for 0.03% of the portfolio, ranked #267.

Cahill Financial Advisors first reported a position in IBB in Q3 2017 and has held it in 19 quarters since. The position peaked at $519K in Q4 2022. 731 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Cahill Financial Advisors held 1,370 shares of iShares Biotechnology ETF worth $261K as of Q2 2026.
  • Cahill Financial Advisors sold 58 iShares Biotechnology ETF shares in Q2 2026, an estimated $9.97K.
  • iShares Biotechnology ETF made up 0.03% of Cahill Financial Advisors's portfolio in Q2 2026, its #267 holding.
  • Cahill Financial Advisors first reported a position in iShares Biotechnology ETF in Q3 2017 and has held it in 19 quarters since.
  • Cahill Financial Advisors's iShares Biotechnology ETF position peaked at $519K in Q4 2022.
  • 731 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Cahill Financial Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.